| Breakdown | TTM | Mar 2024 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.03M | 74.35M | 72.52M | 54.44M | 48.09M | 47.78M |
| Gross Profit | 3.69M | 17.53M | 12.61M | 9.84M | 12.42M | 5.57M |
| EBITDA | 1.82M | 3.01M | 1.30M | 2.34M | 8.45M | 2.61M |
| Net Income | -2.53M | -1.94M | -3.24M | -1.24M | 5.36M | 309.76K |
Balance Sheet | ||||||
| Total Assets | 42.82M | 41.20M | 45.51M | 33.20M | 28.95M | 22.85M |
| Cash, Cash Equivalents and Short-Term Investments | 9.07M | 10.14M | 7.65M | 5.14M | 6.82M | 2.97M |
| Total Debt | 22.36M | 15.47M | 20.79M | 12.01M | 7.35M | 4.84M |
| Total Liabilities | 33.99M | 26.52M | 30.45M | 21.96M | 15.66M | 10.48M |
| Stockholders Equity | 8.78M | 14.89M | 14.99M | 11.17M | 13.28M | 12.37M |
Cash Flow | ||||||
| Free Cash Flow | -5.19M | 6.28M | -9.99M | 2.49M | 2.51M | 1.27M |
| Operating Cash Flow | -3.18M | 7.38M | -9.08M | 5.05M | 3.62M | 2.49M |
| Investing Cash Flow | -1.13M | -1.03M | -807.00K | -2.55M | -3.22M | -733.46K |
| Financing Cash Flow | 8.01M | -4.39M | 8.18M | -3.63M | 2.31M | -2.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $25.08M | 5.95 | 16.33% | ― | ― | ― | |
57 Neutral | $31.23M | -7.23 | -5.95% | 7.58% | 50.00% | 18.73% | |
46 Neutral | $22.66M | -21.45 | -12.54% | ― | 1.55% | 69.81% | |
44 Neutral | $36.32M | -0.59 | -131.65% | ― | -22.62% | 21.73% | |
42 Neutral | $14.86M | -0.76 | -95.31% | ― | -30.85% | -633.50% |